Antibodies IP Seminar

Intellectual property partner Christopher Betti, Ph.D. will be presenting at the Antibodies IP Seminar organized by The Antibody Society (TAbS) and the Pharmaceutical & BioScience Society International (PBSS). Chris will be speaking on the program Lifecycle Protection for Antibody Therapeutics: Patent Term Extension, Data Exclusivity, Purple Book Strategy, and Biosimilar Entry.

TAbS is an international non-profit trade association serving individuals and organizations involved in antibody-related research and development. The mission of TAbS is to provide an international forum across all career levels for the field of recombinant antibodies, antibody and T-cell receptor engineering, computational systems immunology, and related areas. PBSS is a non-profit professional organization of scientists and other professionals in the life science sector, working in diverse organizations such as the biotechnology and pharmaceutical industries, contract research organizations, life science tools suppliers, academia, and government laboratories. It has 20,000+ participants and is active through six member organizations in the San Francisco Bay Area, San Diego, Boston, Seattle, Vancouver, and Korea, and Japan, some of the largest life science clusters in the world.